146 related articles for article (PubMed ID: 9761751)
21. Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia.
Garayoa M; Man YG; Martínez A; Cuttitta F; Mulshine JL
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):80-5. PubMed ID: 12495935
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity.
Iwanaga K; Sueoka N; Sato A; Hayashi S; Sueoka E
Biochem Biophys Res Commun; 2005 Aug; 333(3):888-95. PubMed ID: 15964549
[TBL] [Abstract][Full Text] [Related]
24. Expression of hnRNP A2/B1 proteins in human cancer cell lines.
Satoh H; Kamma H; Ishikawa H; Horiguchi H; Fujiwara M; Yamashita YT; Ohtsuka M; Sekizawa K
Int J Oncol; 2000 Apr; 16(4):763-7. PubMed ID: 10717246
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous nuclear ribonucleoprotein A2/B1 is a tissue-specific aldosterone target gene with prominent induction in the rat distal colon.
Hernández-Díaz I; Giraldez T; Morales S; Hernandez G; Salido E; Canessa CM; Alvarez de la Rosa D
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G122-31. PubMed ID: 23139218
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
27. Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.
Liu Y; Gao Y; Wu Y; Wu Y; Wang H; Zhang C
J Histochem Cytochem; 2010 Aug; 58(8):695-705. PubMed ID: 20421594
[TBL] [Abstract][Full Text] [Related]
28. Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains.
Kim SH; Dierssen M; Ferreres JC; Fountoulakis M; Lubec G
J Neural Transm Suppl; 2001; (61):273-80. PubMed ID: 11771750
[TBL] [Abstract][Full Text] [Related]
29. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.
Choi HS; Lee HM; Jang YJ; Kim CH; Ryu CJ
Stem Cells; 2013 Dec; 31(12):2647-58. PubMed ID: 23495120
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells.
Yan-Sanders Y; Hammons GJ; Lyn-Cook BD
Cancer Lett; 2002 Sep; 183(2):215-20. PubMed ID: 12065097
[TBL] [Abstract][Full Text] [Related]
32. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
He Y; Rothnagel JA; Epis MR; Leedman PJ; Smith R
Mol Carcinog; 2009 Feb; 48(2):167-79. PubMed ID: 18680105
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
Fielding P; Turnbull L; Prime W; Walshaw M; Field JK
Clin Cancer Res; 1999 Dec; 5(12):4048-52. PubMed ID: 10632338
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
35. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer.
Gu W; Liu W; Shen X; Shi Y; Wang L; Liu H
Ann Diagn Pathol; 2013 Feb; 17(1):14-7. PubMed ID: 22622045
[TBL] [Abstract][Full Text] [Related]
36. [The heterogeneous nuclear ribonucleoprotein A2/B1 expression in non-small cell lung cancer and its clinical significance].
Zhou M; Zhang S; Wang Y; Che G; Chen X; Zhu W; Zhou Q
Zhongguo Fei Ai Za Zhi; 2004 Apr; 7(2):99-103. PubMed ID: 21215000
[TBL] [Abstract][Full Text] [Related]
37. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.
Wu S; Sato M; Endo C; Sakurada A; Dong B; Aikawa H; Chen Y; Okada Y; Matsumura Y; Sueoka E; Kondo T
Lung Cancer; 2003 Aug; 41(2):179-86. PubMed ID: 12871781
[TBL] [Abstract][Full Text] [Related]
38. Neuronal activity induces synaptic delivery of hnRNP A2/B1 by a BDNF-dependent mechanism in cultured hippocampal neurons.
Leal G; Afonso PM; Duarte CB
PLoS One; 2014; 9(10):e108175. PubMed ID: 25286195
[TBL] [Abstract][Full Text] [Related]
39. Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter.
Michelson RJ; Collard MW; Ziemba AJ; Persinger J; Bartholomew B; Huggenvik JI
J Biol Chem; 1999 Oct; 274(43):30510-9. PubMed ID: 10521432
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
